Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
SPDR Series Trust SPDR S&P Biotech ETF
(ARCA:XBI)
Intraday
$83.48
-1.17
[-1.38%]
Get Report
Watch
Perks
Buy
Compare Brokers
$83.48
-1.17
[-1.38%]
At close: Apr 18
Get Report
Watch
Overview
News
Dividends
Short Interest
Latest News for SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI)
SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
Clean Energy, Semiconductors Among Interest-Rate-Sensitive Sectors Hammered Thursday Afternoon On Rate Cut Concerns
Aaron Bry
-
Apr 4, 2024, 4:13PM
Wednesday, February 28, 2024
Biotech Stocks Surge To Start 2024: 'Charts Look Great,' But Will The Trend Continue?
Erica Kollmann
-
Feb 28, 2024, 12:51PM
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
The Arora Report
-
Feb 28, 2024, 12:19PM
Monday, January 08, 2024
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
Shanthi Rexaline
-
Jan 8, 2024, 6:04AM
Wednesday, January 03, 2024
Satori Fund's Dan Niles Names Amazon, Meta Top Stocks To Own In 2024
Adam Eckert
-
Jan 3, 2024, 1:38PM
Thursday, December 21, 2023
Top 7 Trending Stocks On WallStreetBets As Of December 21, 2023 (Via Swaggy Stocks)
Benzinga Newsdesk
-
Dec 21, 2023, 9:23AM
Thursday, December 14, 2023
US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?
Piero Cingari
-
Dec 14, 2023, 1:58PM
Wednesday, December 13, 2023
Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?
Piero Cingari
-
Dec 13, 2023, 12:45PM
Monday, December 04, 2023
Fed Rate Cut Speculations Rattle Stocks, Commodities Slide, Bitcoin Shines: What's Driving Markets Monday?
Piero Cingari
-
Dec 4, 2023, 2:32PM
Friday, December 01, 2023
Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?
Piero Cingari
-
Dec 1, 2023, 2:36PM
Thursday, November 30, 2023
S&P 500, Nasdaq Slip As Tech Underperforms, Oil Reacts to OPEC+: What's Driving Markets Thursday?
Piero Cingari
-
Nov 30, 2023, 2:20PM
Wednesday, November 29, 2023
Stocks Drift Higher On Stronger GDP Data, Oil Rebounds As OPEC+ Mulls Cuts: What's Driving Markets Wednesday?
Piero Cingari
-
Nov 29, 2023, 1:59PM
Tuesday, November 28, 2023
US Stocks Rebound As Treasury Yields, Dollar Fall On Dovish Fed Remarks, Gold Hits $2,040: What's Driving Markets Tuesday?
Piero Cingari
-
Nov 28, 2023, 1:40PM
Friday, September 08, 2023
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
Shanthi Rexaline
-
Sep 8, 2023, 8:42AM
Friday, August 25, 2023
If You Invested $1000 In Vivek Ramaswamy-Founded Roivant When He Declared Presidential Bid, Here's How Much You'd Have Now
Shanthi Rexaline
-
Aug 25, 2023, 8:06AM
Wednesday, June 28, 2023
ETF Returns: Mid-Cap Winners And Losers
Johnny Rice
-
Jun 28, 2023, 4:16PM
Sunday, April 30, 2023
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
Piero Cingari
-
Apr 30, 2023, 10:01AM
Thursday, April 20, 2023
Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
Ryan Glosier
-
Apr 20, 2023, 8:07AM
Friday, April 14, 2023
Thermo Fisher, Principal Financial Group, And Two Promising ETFs Steal The Show On CNBC's 'Final Trades'
Lisa Levin
-
Apr 14, 2023, 9:00AM
Thursday, April 13, 2023
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Vandana Singh
-
Apr 13, 2023, 2:54PM
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
Vandana Singh
-
Apr 13, 2023, 7:38AM
Wednesday, April 12, 2023
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Vandana Singh
-
Apr 12, 2023, 9:46AM
Tuesday, April 11, 2023
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Vandana Singh
-
Apr 11, 2023, 2:28PM
Thursday, April 06, 2023
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Vandana Singh
-
Apr 6, 2023, 1:45PM
Friday, March 31, 2023
Top 5 Best And Worst U.S. Industry ETFs In Q1 2023: AI and Bank Turmoil Shaped Stock Returns
Piero Cingari
-
Mar 31, 2023, 11:34AM
Thursday, March 16, 2023
US Judge Weighs Nationwide Ban On Abortion Pills
Vandana Singh
-
Mar 16, 2023, 8:56AM
Monday, March 13, 2023
Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
Vandana Singh
-
Mar 13, 2023, 8:05AM
Friday, March 10, 2023
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
Vandana Singh
-
Mar 10, 2023, 1:10PM
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Vandana Singh
-
Mar 10, 2023, 11:46AM
Wednesday, March 01, 2023
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Vandana Singh
-
Mar 1, 2023, 1:24PM
Tuesday, January 31, 2023
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
Lisa Levin
-
Jan 31, 2023, 7:55AM
Tuesday, December 27, 2022
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Shanthi Rexaline
-
Dec 27, 2022, 9:11AM
Friday, December 02, 2022
Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
Shanthi Rexaline
-
Dec 2, 2022, 6:01AM
Thursday, December 01, 2022
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
Faith Ashmore
-
Sponsored
Tuesday, November 22, 2022
The 10 Most Shorted ETFs: Which Sectors Saw Short Interest Increase?
Chris Katje
-
Nov 22, 2022, 12:27PM
Monday, November 21, 2022
Devon Energy, Service Now, WR Berkley And This Biotech Play On CNBC's 'Final Trades'
Priya Nigam
-
Nov 21, 2022, 8:14AM
Tuesday, November 01, 2022
What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal
Joel Elconin
-
Nov 1, 2022, 4:28PM
Monday, October 03, 2022
ExxonMobil And Biotech: How To Play A Declining Market
Priya Nigam
-
Oct 3, 2022, 8:50AM
Wednesday, August 31, 2022
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
Shanthi Rexaline
-
Aug 31, 2022, 2:52PM
Thursday, July 14, 2022
CNBC's Final Trades: Biotech, CVS Health, Walt Disney And This Stock That Could Benefit From Taiwan Semiconductor's Earnings Release
Priya Nigam
-
Jul 14, 2022, 10:14AM
Wednesday, July 13, 2022
CNBC Fast Money Favorites: AMD, CVS, And One Of The Worst Performers In The S&P 500 Today
AJ Fabino
-
Jul 13, 2022, 2:15PM
Friday, July 01, 2022
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
Shanthi Rexaline
-
Jul 1, 2022, 5:26AM
Monday, May 30, 2022
As COVID Subsidies, Here Are 8 Infectious Diseases That Could Emerge As Potent Threats
Shanthi Rexaline
-
May 30, 2022, 10:51AM
Wednesday, May 25, 2022
PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst
Joel Elconin
-
May 25, 2022, 2:40PM
Monday, April 04, 2022
CNBC's Final Call: Newmont, Biotech ETF And This Energy Stock
Craig Jones
-
Apr 4, 2022, 8:22AM
Friday, January 28, 2022
Abbott Labs Outlook Cools the Omicron Led Testing Boom
Dana Salzarulo
-
Sponsored
Wednesday, January 26, 2022
15 Charts All Traders Should Look At Every Morning
Asli Tolon Coskun
-
Jan 26, 2022, 11:35AM
Monday, January 03, 2022
Whitney Tilson Names Cannabis ETF 'Favorite Pick For 2022' But Clock Is Ticking To Change US Regulations
Wayne Duggan
-
Jan 3, 2022, 3:27PM
Wednesday, November 03, 2021
Wednesdays With Wedbush On PreMarket Prep Plus
Joel Elconin
-
Nov 3, 2021, 3:37PM
Show more
